Announce Date | 06/10/2025 |
EPS Normalized Actual | $0.52 (Miss by $-0.003) |
EPS GAAP Actual | $0.52 (Miss by $-0.003) |
Revenue Actual | $1.911B |
Revenue Surprise | Beat by $1911M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2029 | 4.24 | 14.59 | 4.16116 | 4.39267 | 2 |
Jan 2029 | 4.19 | 14.76 | 4.02734 | 4.34056 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 0.53 | 0.53 | 1.911B | 100% | 1911M |
FQ1 2025 (Feb 2025) | 0.35 | 0.35 | 1.698B | 100% | 1698M |
FQ4 2024 (Oct 2024) | 0.67 | 0.67 | 2.038B | 100% | 2038M |
FQ2 2020 (Apr 2020) | -0.0199 | -0.0199 | 0.8421B | 100% | 842.1M |
FQ3 2020 (Jul 2020) | 0.0752 | 0.0752 | 0.9559B | 100% | 955.9M |
FQ4 2020 (Oct 2020) | 0.0897 | 0.0897 | 1.0125B | 100% | 1012.5M |
FQ1 2021 (Jan 2021) | 0 | 0 | 0.8318B | 100% | 831.8M |
FQ3 2023 (Jul 2023) | 0.66 | 0.66 | 1.861B | 100% | 1861M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Feb 2028) | 0.5973 | -- | 0.57644 | 0.62392 | 4 |
FQ4 2027 (Nov 2027) | 1.057 | -- | 1.02009 | 1.10411 | 5 |
FQ3 2027 (Aug 2027) | 1.0784 | -- | 1.04074 | 1.12647 | 3 |
FQ2 2027 (May 2027) | 0.7927 | -- | 0.76502 | 0.82803 | 3 |
FQ1 2027 (Jan 2027) | 0.562 | -- | 0.55187 | 0.57282 | 2 |
FQ4 2026 (Oct 2026) | 0.9984 | -- | 0.98041 | 1.01762 | 3 |
FQ3 2026 (Jul 2026) | 0.93485 | -- | 0.918 | 0.95285 | 3 |
FQ2 2026 (May 2026) | 0.6486 | 18.29 | 0.62595 | 0.67751 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Feb 2028) | 3.19B | -- | 3.11B | 3.3B | 5 |
FQ4 2027 (Nov 2027) | 2.84B | -- | 2.76B | 2.93B | 6 |
FQ3 2027 (Aug 2027) | 2.71B | -- | 2.64B | 2.8B | 6 |
FQ2 2027 (May 2027) | 2.58B | -- | 2.51B | 2.67B | 6 |
FQ1 2027 (Jan 2027) | 3.05B | -- | 3.01B | 3.1B | 3 |
FQ4 2026 (Oct 2026) | 2.92B | -- | 2.88B | 2.96B | 3 |
FQ3 2026 (Jul 2026) | 2.79B | -- | 2.75B | 2.83B | 3 |
FQ2 2026 (May 2026) | 2.03B | 5.67 | 1.97B | 2.1B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 0.53 | 0.53 | 100% | |
FQ1 2025 (Feb 2025) | 0.35 | 0.35 | 100% | |
FQ4 2024 (Oct 2024) | 0.67 | 0.67 | 100% | |
FQ2 2020 (Apr 2020) | -0.0199 | -0.0199 | 100% | |
FQ3 2020 (Jul 2020) | 0.0752 | 0.0752 | 100% | |
FQ4 2020 (Oct 2020) | 0.0897 | 0.0897 | 100% | |
FQ1 2021 (Jan 2021) | 0 | 0 | NAN% | |
FQ3 2023 (Jul 2023) | 0.66 | 0.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $1.91B | $1911M | 100% |
FQ1 2025 (Feb 2025) | $0B | $1.7B | $1698M | 100% |
FQ4 2024 (Oct 2024) | $0B | $2.04B | $2038M | 100% |
FQ2 2020 (Apr 2020) | $0B | $0.84B | $842.1M | 100% |
FQ3 2020 (Jul 2020) | $0B | $0.96B | $955.9M | 100% |
FQ4 2020 (Oct 2020) | $0B | $1.01B | $1012.5M | 100% |
FQ1 2021 (Jan 2021) | $0B | $0.83B | $831.8M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.86B | $1861M | 100% |